首页> 外国专利> Use of resveratrol and/or their analogues e.g. for treating platelet aggregation and cancellation of resistance to acetylsalicylic acid or nonsteroidal anti-inflammatory drugs and/or repealing paradoxical reaction to acetylsalicylic acid

Use of resveratrol and/or their analogues e.g. for treating platelet aggregation and cancellation of resistance to acetylsalicylic acid or nonsteroidal anti-inflammatory drugs and/or repealing paradoxical reaction to acetylsalicylic acid

机译:白藜芦醇和/或其类似物的使用用于治疗血小板聚集和消除对乙酰水杨酸或非甾体类抗炎药的耐药性和/或消除对乙酰水杨酸的悖论反应

摘要

Use of resveratrol and/or their analogues for cancellation of resistance to acetylsalicylic acid (ASA) or other nonsteroidal anti-inflammatory drugs (NSAIDs) and/or repealing the paradoxical reaction to acetylsalicylic acid (PRASA) or other NSAIDs, is claimed. An independent claim is also included for a combination comprising at resveratrol and/or their analogs and nonsteroidal anti-inflammatory drugs for preventing or treating platelet aggregation. ACTIVITY : Anticoagulant; Thrombolytic; Hemostatic; Antiinflammatory; Gastrointestinal-Gen; Cardiant; Vasotropic; Antidiabetic; Antilipemic. Test details are described but no results given. MECHANISM OF ACTION : None given.
机译:要求使用白藜芦醇和/或其类似物消除对乙酰水杨酸(ASA)或其他非甾体抗炎药(NSAID)的抗性和/或废除对乙酰水杨酸(PRASA)或其他NSAID的反常反应。还包括针对白藜芦醇和/或其类似物与用于预防或治疗血小板凝集的非甾体抗炎药的组合的独立权利要求。活性:抗凝剂;溶栓;止血药消炎(药;胃肠源;卡迪恩变压性抗糖尿病抗血脂。描述了测试细节,但未给出结果。作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号